DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7)
- CAS No.
- 204318-14-9
- Chemical Name:
- DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7)
- Synonyms
- SMT487;DOTATOC;SMT 487;SMT-487;NOTA-TOC;EDOTREOTIDE;EDOTREOTIDUM;DOTA-TOC204318-14-9;DOTA-[TYR3]-OCTREOTIDE;[DOTA-DPHE1, TYR3]OCTREOTIDE
- CBNumber:
- CB2293419
- Molecular Formula:
- C65H92N14O18S2
- Molecular Weight:
- 1421.65
- MOL File:
- 204318-14-9.mol
- MSDS File:
- SDS
- Modify Date:
- 2024/7/2 8:55:03
| alpha | 22D -14.75° (c = 0.52 in 95% acetic acid) |
|---|---|
| Boiling point | 1723.7±65.0 °C(Predicted) |
| Density | 1.46±0.1 g/cm3(Predicted) |
| pka | 1.83±0.10(Predicted) |
| form | Solid |
| color | White to off-white |
| Sequence | DOTA-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Threoninol (Disulfide bridge Cys2-Cys7) |
DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7) Preparation Products And Raw materials
Raw materials
Preparation Products
Global( 84)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | Inquiry |
|---|---|---|---|---|---|
| Nantong Guangyuan Chemicl Co,Ltd | +undefined17712220823 | China | 616 | 58 | Inquiry |
| Alpha Biopharmaceuticals Co., Ltd | +86-15542445688 | China | 888 | 58 | Inquiry |
| ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | China | 32760 | 60 | Inquiry |
| career henan chemical co | +86-0371-86658258 +8613203830695 | China | 29898 | 58 | Inquiry |
| Shenzhen Nexconn Pharmatechs Ltd | +86-755-89396905 +86-15013857715 | China | 10318 | 58 | Inquiry |
| BOC Sciences | +1-631-485-4226 | United States | 19553 | 58 | Inquiry |
| Chongqing Chemdad Co., Ltd | +86-023-6139-8061 +86-86-13650506873 | China | 39916 | 58 | Inquiry |
| Fuxin Pharmaceutical | +86-021-021-50872116 +8613122107989 | China | 10297 | 58 | Inquiry |
| Hebei Yanxi Chemical Co., Ltd. | +86-17531190177; +8617531190177 | China | 5907 | 58 | Inquiry |
| TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | United States | 19892 | 58 | Inquiry |
204318-14-9(DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7))Related Search:
chevron_left
1of3
chevron_right
DOTA-[TYR3]-OCTREOTIDE
DOTATOC
DOTA-FCYWKTCT-OL (DISULFIDE BRIDGE: 2-7)
DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7)
[DOTA-DPHE1, TYR3]OCTREOTIDE
DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THREONINOL
EDOTREOTIDE
4,7,10-TRICARBOXYMETHYL-1,4,7,10-TETRAAZA-CYCLODODECAN-1-YL-ACETYL-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-L-THREONINOL, (DISULFIDE BOND)
DOTA-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Threoninol (Disulfide bridge Cys2-Cys7)
EDOTREOTIDUM
L-Cysteinamide, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-Lthreonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2)-disulfide
DOTA-TOC204318-14-9
2-[4-[2-[[(2R)-1-[[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-4-[[(2R,3R)-1,3-dihydroxybutan-2-yl]carbamoyl]-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-7,10-bis(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid
DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7)DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7)
L-Cysteinamide, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide
SMT 487
SMT487
SMT-487
somatostatin,DOTATOC,Edotreotide,inhibit,cancer,Inhibitor,radionuclides,SDZ-SMT 487
DOTA-(Tyr3)-Octreotide acetate salt
DOTA-(Tyr?)-Octreotide acetate salt
NOTA-TOC
DOTA-[Tyr3]Octreotide, DOTA-TOC, Edotreotide
204318-14-9
C65H92N14O18S2
peptide